Better care for women experiencing hormonal changes at midlife could lead to an eightfold increase in the menopause treatment market by 2030—to $40 billion.
Education
- PhD, bioengineering, University of Washington
- BA, biology, Williams College
Sarah Chamberlain works at the intersection of health care and social impact. She serves on the North America leadership team for both the Social Impact and Health Care practices at Boston Consulting Group.
Sarah has extensive experience supporting philanthropies and private sector entities with a focus on high-impact strategy development. Her work spans industries within the health care sector, from maternal health and family planning to HIV/TB, and covers functions from R&D to product introduction and service delivery.
